Fascinating news from Hungary's Richter

Key drug to hit shelves in Western Europe soon.

Teva to close or sell manufacturing plant in Hungary

500 employees to be sacked from the Gödöllő plant.

Hungary Richter raises revenue guidance for 2017

Operating profit margin also seen higher.

Profit soars at Hungary's Richter

Leading pharma reports robust Q1 results.

Hungary Richter quarterly profits seen up with help from Russia

Robust quarter projected.

British pharma company to launch giant investment project in Hungary

18 billion forint investment at the door.

Fund managers turn their back on Hungary's Richter

Magyar Telekom and OTP are the top picks.

ANALYST VIEW - Jefferies trims target price for Hungary's Richter

'Buy' rating remains.

Hungary Richter reports robust performance for Q4 2016

Profit doubled, yet share price is falling.

Hungary Richter may be thankful to Russia

Analysts expect major profit growth for Q416.

Hungary Richter inks distribution & supply deal with Allergan

Levosert goes to Europe.

Hungary Richter CEO says they must be "much more aggressive"

In female healthcare product acquistions.

Hungarian pharma Richter withdraws pegfilgrastim marketing application

Negotiating the curves of the biosimilar scene.

Hungary Richter delivers good news again

ANALYST VIEW - Jefferies sharply raises target price for Hungary's Richter

The rating is 'Buy'.

Hungary Richter has greatly improved expectations for 2016

Brighter hopes for Russia.

Hungary's Richter beats Q3 expectations, one-offs help

Profit guidance raised for 2016.

Hungary Richter Q3 profit seen up sharply from low base

80% growth seen in net profit.

Hungary Richter inks deal for exclusive distribution of DM Bio product

Hungarian government may nationalise again